3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Alcohol Drinking
5
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Substance-Related Disorders
1
Social Isolation
1
Smoking Cessation
1
Risk-Taking
1
Pancreatic Cyst
1
Pain
1
Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Flushing
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Driving Under the Influence
1
Depression
1
Colorectal Neoplasms
1
Carney Complex
1
Cardiovascular Diseases
1
Binge-Eating Disorder
1
Binge Drinking
1
Alzheimer Disease
1
Agnosia
1
Interventions
Dexamethasone
13
daratumumab
7
Bortezomib
7
Cyclophosphamide
6
Calcium Dobesilate
5
ixazomib
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
auricularum
4
venetoclax
3
belantamab mafodotin
3
Specimen Handling
3
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
3
pomalidomide
2
isatuximab
2
X-Rays
2
Polymerase Chain Reaction
2
Phantoms, Imaging
2
Magnetic Resonance Spectroscopy
2
Clinical Protocols
2
Biopsy
2
siltuximab
1
Valganciclovir
1
Tissue Banks
1
Therapeutics
1
Stem Cell Transplantation
1
Spectrometry, Fluorescence
1
Positron-Emission Tomography
1
Pharmaceutical Preparations
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
Ethanol
×
1 year
×
Clear all
No trials found.